(株)サイトリ細胞研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 情報・通信 | 3750/E05443 | SEVEN SEAS HOLDINGS CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2023/03/17 | 日証協 | 99,400株 | +193.69% | 70,955株 | +143.75% | 42,765株 | +3.64% | 2,300株 | -69.33% |
2023/03/10 | 日証協 | 33,845株 | -34.79% | 29,110株 | +265.93% | 41,265株 | -16.24% | 7,500株 | +13.64% |
2023/03/03 | 日証協 | 51,900株 | -1.33% | 7,955株 | +65.38% | 49,265株 | 0% | 6,600株 | +78.38% |
2023/02/24 | 日証協 | 52,600株 | +1.74% | 4,810株 | +60.33% | 49,265株 | +1.86% | 3,700株 | +27.59% |
2023/02/17 | 日証協 | 51,700株 | -2.08% | 3,000株 | -46.19% | 48,365株 | +0.83% | 2,900株 | -29.27% |
2023/02/10 | 日証協 | 52,800株 | +4.76% | 5,575株 | +135.73% | 47,965株 | +5.96% | 4,100株 | +241.67% |
2023/02/03 | 日証協 | 50,400株 | +1.2% | 2,365株 | -93.02% | 45,265株 | -57.12% | 1,200株 | -92.86% |
2023/01/27 | 日証協 | 49,800株 | +173.63% | 33,900株 | +816.22% | 105,565株 | +16.95% | 16,800株 | +630.43% |
2023/01/20 | 日証協 | 18,200株 | -78.79% | 3,700株 | -97.4% | 90,265株 | +2.27% | 2,300株 | +283.33% |
2023/01/13 | 日証協 | 85,810株 | +0.23% | 142,320株 | -0.21% | 88,265株 | +0.68% | 600株 | -25% |
2023/01/06 | 日証協 | 85,610株 | -3.6% | 142,620株 | +88.99% | 87,665株 | -2.23% | 800株 | -65.22% |
2022/12/30 | 日証協 | 88,810株 | -1% | 75,465株 | -50.05% | 89,665株 | +0.56% | 2,300株 | +15% |
2022/12/23 | 日証協 | 89,710株 | +0.79% | 151,075株 | -0.13% | 89,165株 | -1.55% | 2,000株 | +81.82% |
2022/12/16 | 日証協 | 89,010株 | -3.16% | 151,275株 | -2.48% | 90,565株 | -2.05% | 1,100株 | +22.22% |
2022/12/09 | 日証協 | 91,910株 | -3.36% | 155,120株 | -3.6% | 92,465株 | -0.64% | 900株 | -57.14% |
2022/12/02 | 日証協 | 95,110株 | +2.59% | 160,920株 | +1.19% | 93,065株 | +2.08% | 2,100株 | +250% |
2022/11/18 | 日証協 | 95,610株 | -1.04% | 164,330株 | -0.42% | 92,465株 | +1.87% | 3,000株 | +50% |
2022/11/11 | 日証協 | 96,610株 | 0% | 165,020株 | -0.06% | 90,765株 | +0.11% | 2,000株 | +400% |
2022/11/04 | 日証協 | 96,610株 | -2.82% | 165,120株 | -1.76% | 90,665株 | -1.09% | 400株 | -55.56% |
※株式分割は考慮していませんのでご注意ください。